Standout Papers

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer 2020 2026 2022 2024364
  1. Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer (2020)
    Charles Dolladille, Stéphane Éderhy et al. JAMA Oncology

Immediate Impact

1 by Nobel laureates 67 standout
Sub-graph 1 of 23

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
2 intermediate papers

Works of Anne‐Flore Plane being referenced

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
2020 Standout

Author Peers

Author Last Decade Papers Cites
Anne‐Flore Plane 167 459 60 166 12 629
Angélique Da Silva 91 429 49 171 17 546
Krishna S. Gunturu 83 334 76 146 28 537
Jean Bernard Durand 323 335 96 96 16 633
Hannah Gilman 360 449 98 140 20 736
Sarah Hartmann 334 394 90 120 8 649
Marcella Occelli 220 340 140 173 28 670
Adam Corken 110 289 145 108 15 725
Yuanyu Qian 238 318 75 147 16 565
Thompson Cb 173 261 47 125 9 617
Carina Hillenbach 107 375 110 314 11 617

All Works

Loading papers...

Rankless by CCL
2026